Telomir Pharmaceuticals’ anti-aging expert to present pre-clinical data

Telomir Pharmaceuticals announced that anti-aging expert and New York Times bestselling author Michael Roizen, MD, will present pre-clinical research on Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024. Dr. Roizen serves as Telomir’s special advisor on age reversal. Telomir’s pre-clinical research supports its belief that enlongating telomeres, which are repetitive DNA sequences at the end of chromosomes that protect chromosomes from becoming frayed or tangled, could stimulate stem cell renewal and provide a treatment for age-related conditions like osteoarthritis. “Our event at the National Press Club will provide us with an opportunity to share Telomir-1’s potential with the public on a national stage,” stated Chris Chapman, MD, co-founder, chairman, chief executive officer and president of Telomir Pharmaceuticals. “As part of the event, we will showcase our pre-clinical data which we believe demonstrates that Telomir-1 may potentially treat age-related conditions and prolong human life.”